Mary Thistle - 28 Oct 2021 Form 3 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Director
Signature
/s/ Jared Cohen, as Attorney-in-fact
Issuer symbol
TRDA
Transactions as of
28 Oct 2021
Net transactions value
$0
Form type
3
Filing time
28 Oct 2021, 20:57:29 UTC
Previous filing
22 Jun 2021
Next filing
20 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TRDA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 46,604 $8.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in 48 equal monthly installments, commencing on April 21, 2021 (the "Vesting Start Date"), such that the option shall be fully vested on the four-year anniversary of the Vesting Start Date.

Remarks:

Exhibit 24 - Power of Attorney